HbOT may provide a fresh lease of life for patients with ME and CFS

Summary

• Hyperbaric oxygen therapy (HbOT) may provide some hope for those with Chronic Fatigue Syndrome (CFS) & Myalgic Encephalomyelitis (ME), according to current studies.
• A significant number of patients in the trial reported that their symptoms had continued to improve six months after the HBOT therapy had ceased, indicating that the advantages of the procedure were long-lasting.
• The possibility that HBOT might provide a long-term cure for ME and CFS is hopeful news for people who are afflicted with these disorders.
• Several chronic illnesses, such as ME and CFS, are significantly exacerbated by inflammation.
• HBOT may provide a fresh lease of life for patients with ME and CFS thanks to its capacity to lower inflammation, strengthen the immune system, and encourage recovery.
• We do not recommend Hyperbaric oxygen Therapy as a replacement for conventional treatments, if you are unsure please consult your doctor.

Can HbOT help with CFS & ME?

ME (Myalgic Encephalomyelitis) and CFS (Chronic Fatigue Syndrome) are incapacitating illnesses that can leave people feeling worn out, in pain, and unable to do even the most basic duties. There is presently no known treatment for these illnesses, which impact millions of individuals globally. Hyperbaric oxygen therapy (HBOT) may, however, provide some hope for those with ME and CFS, according to current studies. 

100% oxygen is breathed in a pressurised chamber as part of the therapy known as HBOT. As a result of this process, the body receives more oxygen, which can aid in promoting healing, boosting immunity, and reducing inflammation. It has been used successfully to treat a variety of medical ailments, from wound healing to decompression sickness. 

The utility of HBOT in the treatment of ME and CFS was investigated in a study that was published in the Journal of Chronic Fatigue Syndrome. 48 people took part in the trial and received HBOT therapy for eight weeks. The findings demonstrated that most individuals’ complaints, including decreased tiredness, enhanced cognitive function, and decreased pain, significantly improved. 

A significant number of patients in the trial reported that their symptoms had continued to improve six months after the HBOT therapy had ceased, indicating that the advantages of the procedure were long-lasting. The possibility that HBOT might provide a long-term cure for ME and CFS is hopeful news for people who are afflicted with these disorders. 

Reducing inflammation in the body is one of HBOT’s main advantages. Several chronic illnesses, such as ME and CFS, are significantly exacerbated by inflammation. HBOT can aid in the relief of pain and the enhancement of general health and well-being by lowering inflammation. 

HBOT’s capacity to strengthen the immune system is another advantage. As ME and CFS are frequently associated with immunological dysfunction, this is especially crucial for patients who suffer from these diseases. HBOT works to strengthen the immune system, which lowers the risk of infection and other diseases while also enhancing general health. 

According to the study, participants tolerated HBOT well, with no significant side effects noted. This points to the safety and efficacy of HBOT, which is a crucial factor for people considering it as a therapy option. 

In conclusion, the application of HBOT in the management of ME and CFS is a welcome advance for patients affected by these severe illnesses. The findings of the trial, which were published in the Journal of Chronic Fatigue Syndrome, point to HBOT as a potentially beneficial, safe, and long-lasting therapy option. The findings of this study are positive and give patients who are battling ME and CFS hope, even if further research is required to completely understand the advantages of HBOT in the treatment of these disorders. 

The findings of this study do, however, imply that HBOT may be worth looking into further if you are thinking about it as a therapeutic option. HBOT may provide a fresh lease of life for patients with ME and CFS thanks to its capacity to lower inflammation, strengthen the immune system, and encourage recovery.

Studies in to CFS, ME and HbOT

March 2013 – The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome